Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Dose-Response Study of CM4620 Injectable Emulsion (CM4620-IE) in Patients With Acute Pancreatitis and Accompanying Systemic Inflammatory Response Syndrome (SIRS)

NCT03401190 is registered in ClinicalTrials.gov with CalciMedica, Inc. as lead sponsor.

NCT NCT03401190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03401190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Dose-Response Study of CM4620 Injectable Emulsion (CM4620-IE) in Patients With Acute Pancreatitis and Accompanying Systemic Inflammatory Response Syndrome (SIRS)
Lead sponsor
CalciMedica, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 12, 2018
Completion date
April 30, 2019
Enrollment
21 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acute pancreatitis, systemic inflammatory response syndrome